Citadel Advisors’s enVVeno Medical NVNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $116K | Buy |
29,098
+2,677
| +10% | +$10.7K | ﹤0.01% | 5216 |
|
|
2025
Q1 | $69.5K | Sell |
26,421
-79,895
| -75% | -$210K | ﹤0.01% | 5263 |
|
|
2024
Q4 | $321K | Buy |
106,316
+105,311
| +10,479% | +$318K | ﹤0.01% | 4458 |
|
|
2024
Q3 | $3.38K | Sell |
1,005
-6,140
| -86% | -$20.6K | ﹤0.01% | 5544 |
|
|
2024
Q2 | $37.5K | Sell |
7,145
-38,416
| -84% | -$202K | ﹤0.01% | 5258 |
|
|
2024
Q1 | $248K | Buy |
45,561
+5,638
| +14% | +$30.7K | ﹤0.01% | 4587 |
|
|
2023
Q4 | $205K | Buy |
+39,923
| New | +$205K | ﹤0.01% | 4575 |
|
|
2023
Q3 | – | Sell |
-45,086
| Closed | -$139K | – | 6297 |
|
|
2023
Q2 | $139K | Buy |
+45,086
| New | +$139K | ﹤0.01% | 4603 |
|
|
2023
Q1 | – | Sell |
-11,087
| Closed | -$56.5K | – | 6350 |
|
|
2022
Q4 | $56.5K | Sell |
11,087
-8,896
| -45% | -$45.4K | ﹤0.01% | 5236 |
|
|
2022
Q3 | $126K | Buy |
+19,983
| New | +$126K | ﹤0.01% | 5030 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6640 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6877 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6940 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6879 |
|
|
2021
Q2 | – | Sell |
-11,512
| Closed | -$77K | – | 6866 |
|
|
2021
Q1 | $77K | Buy |
+11,512
| New | +$77K | ﹤0.01% | 5961 |
|
|
2020
Q4 | – | Sell |
-5,150
| Closed | -$56K | – | 5414 |
|
|
2020
Q3 | $56K | Buy |
+5,150
| New | +$56K | ﹤0.01% | 4372 |
|
|
2019
Q1 | – | Sell |
-561
| Closed | -$20K | – | 4873 |
|
|
2018
Q4 | $20K | Buy |
+561
| New | +$20K | ﹤0.01% | 4276 |
|